4//SEC Filing
Drake Lorin 4
Accession 0001181431-13-012527
CIK 0001369786other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 8:08 PM ET
Size
6.7 KB
Accession
0001181431-13-012527
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Stock Option to Buy
2013-02-21+8,499→ 8,499 totalExercise: $16.45Exp: 2023-02-21→ Common Stock (8,499 underlying) - Award
Common Stock
2013-02-21+4,924→ 22,478 total
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 21, 2014.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeother
Related Parties
1- filerCIK 0001517897
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 8:08 PM ET
- Size
- 6.7 KB